HRD1 sensitizes breast cancer cells to Tamoxifen by promoting S100A8 degradation
Sign Up to like & getrecommendations! Published in 2017 at "Oncotarget"
DOI: 10.18632/oncotarget.15797
Abstract: Estrogen receptor alpha positive (ER+) of breast cancer could develop resistance to antiestrogens including Tamoxifen. Our previous study showed that the E3 ubiquitin ligase HRD1 played an important role in anti-breast cancer. However, its role… read more here.
Keywords: cells tamoxifen; hrd1; s100a8; breast cancer ... See more keywords